Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 17: AMD IV

14:30 - 16:00 | 22 September | Room: Room C1.

Back to Previous

14:30Comparative assessment of retinal fluid in patients treated with brolucizumab and aflibercept: 36–48 Week data from HAWK and HARRIER
R. Tadayoni France
14:36Shortterm assessment of retinal function following 2RT laser treatment for intermediate AMD: a pilot study including electrophysiology
A. Cusumano Italy
14:42Comparison of physician and nurseadministered intravitreal injections of antivascular endothelial growth factor, a randomized noninferiority trial
S. Bolme Norway
14:48Treatment patterns in prior ranibizumabtreated patients with neovascular agerelated macular degeneration: realworld outcomes from the LUMINOUS study
F. Holz Germany
14:54Patient tailored perimetry in geographic atrophy secondary to agerelated macular degeneration: probing of cone and rodfunction in the junctional zone with highspatial resolution
M. Pfau Germany
15:00Evaluation of the frequency of complement factor I gene polymorphism in a Turkish age related macular degeneration population
S. Kadayifcilar Turkey
15:06Dynamics of systemic free VEGFA in AMD patients during antiVEGF treatment with ranibizumab versus aflibercept
A. Wolf Germany
15:12Following excitement and anxiety response under intravitreal injection: The FEAR study
M. Zinkernagel Switzerland
15:18The q12w dosing status with brolucizumab in patients with neovascular agerelated macular degeneration and the impact of baseline characteristics: Results from the Phase III HAWK and HARRIER trials
J. Monés Spain
15:24Subthreshold nanosecond laser intervention to slow progression in intermediate agerelated macular degeneration
R. Guymer Australia
15:30A population based study on the prevalence and risk factors of agerelated macular degeneration in Northern Iran The Gilan Eye Study
S. Moradian Iran, Islamic Republic of
15:36Tenyear outcome of antiVEGF treatment in patients with agerelated macular degeneration
H. Gerding Switzerland
15:42Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks
V. Capuano France
15:48Prevalence of age related macular degeneration (AMD) in high altitude Himalayan population
K. Biswas India
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait